| Monday, December 7th 2020 View the recent #TreatER webcast seminar – World’s 1st clinical trial with #CDNF: Aiming for a breakthrough in CDNF Twitter | Monday, November 23rd 2020 Recordings of TreatER webcast seminar on #CDNF for #Parkinsons are now available on Herantis’ website Twitter | Monday, September 28th 2020 Registration open for TreatER webcast seminar – World’s 1st CDNF clinical trial: Aiming for a breakthrough in Parkinson’s Twitter | Wednesday, September 16th 2020 Recording on CDNF webinar available: CDNF Phase I-II Study Met Primary Endpoints of Safety and Tolerability at 12 months Twitter | Thursday, August 27th 2020 Renishaw announces completion of clinical trial extension study, using its innovative drug delivery system in the investigation of CDNF as a treatment for Parkinson’s disease Twitter | Monday, July 27th 2020 TreatER webcast seminar – World’s 1st CDNF clinical trial: Aiming for a breakthrough in Parkinson’s Twitter | Tuesday, April 14th 2020 Parkinsonsawarenessweek marked by an article on our clinical study with CDNF, aiming at breakthrough in Parkinsons Twitter | Tuesday, March 10th 2020 Interview of Herantis Pharma CEO on Q4 2019 by Direkt Studios Youtube | Friday, February 28th 2020 CDNF phase I-II clinical study webinar: Topline data of the 6-month treatment period Youtube | Wednesday, February 26th 2020 Renishaw announces completion of the main part of a multi-centre clinical trial Twitter
